Research ExplorerPublicationsCirculating microRNAs vs. aortic diameter in bicuspid aortic...

Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy

Standard

Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy. / Naito, Shiho; Petersen, Johannes; Sequeira-Gross, Tatiana; Zeller, Tanja; Reichenspurner, Hermann; Girdauskas, Evaldas.

In: ASIAN CARD THORAC AN, Vol. 30, No. 8, 10.2022, p. 947-953.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Naito, S, Petersen, J, Sequeira-Gross, T, Zeller, T, Reichenspurner, H & Girdauskas, E 2022, 'Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy', ASIAN CARD THORAC AN, vol. 30, no. 8, pp. 947-953. https://doi.org/10.1177/0218492320927233

APA

Naito, S., Petersen, J., Sequeira-Gross, T., Zeller, T., Reichenspurner, H., & Girdauskas, E. (2022). Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy. ASIAN CARD THORAC AN, 30(8), 947-953. https://doi.org/10.1177/0218492320927233

Vancouver

Naito S, Petersen J, Sequeira-Gross T, Zeller T, Reichenspurner H, Girdauskas E. Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy. ASIAN CARD THORAC AN. 2022 Oct;30(8):947-953. https://doi.org/10.1177/0218492320927233

Bibtex

@article{ffebeb75731747c3b730db13480da930,
title = "Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy",
abstract = "There is growing clinical need and interest to implement novel risk prediction tools in bicuspid aortic valve-associated proximal aortic disease, so-called bicuspid aortic valve aortopathy. Inherent limitations of the diameter-based risk stratification for adverse aortic events in bicuspid aortic valve aortopathy patients have recently been recognized. Therefore, alternative diagnostic tools and subsequent adjustments in the treatment guidelines are urgently needed. Herein, we summarize the current evidence on recent diagnostic developments to improve risk stratification in bicuspid aortic valve aortopathy, including circulating microRNAs as biomarkers to predict the progression of aortic disease.",
author = "Shiho Naito and Johannes Petersen and Tatiana Sequeira-Gross and Tanja Zeller and Hermann Reichenspurner and Evaldas Girdauskas",
year = "2022",
month = oct,
doi = "10.1177/0218492320927233",
language = "English",
volume = "30",
pages = "947--953",
journal = "ASIAN CARD THORAC AN",
issn = "0218-4923",
publisher = "SAGE Publications",
number = "8",

}

RIS

TY - JOUR

T1 - Circulating microRNAs vs. aortic diameter in bicuspid aortic valve aortopathy

AU - Naito, Shiho

AU - Petersen, Johannes

AU - Sequeira-Gross, Tatiana

AU - Zeller, Tanja

AU - Reichenspurner, Hermann

AU - Girdauskas, Evaldas

PY - 2022/10

Y1 - 2022/10

N2 - There is growing clinical need and interest to implement novel risk prediction tools in bicuspid aortic valve-associated proximal aortic disease, so-called bicuspid aortic valve aortopathy. Inherent limitations of the diameter-based risk stratification for adverse aortic events in bicuspid aortic valve aortopathy patients have recently been recognized. Therefore, alternative diagnostic tools and subsequent adjustments in the treatment guidelines are urgently needed. Herein, we summarize the current evidence on recent diagnostic developments to improve risk stratification in bicuspid aortic valve aortopathy, including circulating microRNAs as biomarkers to predict the progression of aortic disease.

AB - There is growing clinical need and interest to implement novel risk prediction tools in bicuspid aortic valve-associated proximal aortic disease, so-called bicuspid aortic valve aortopathy. Inherent limitations of the diameter-based risk stratification for adverse aortic events in bicuspid aortic valve aortopathy patients have recently been recognized. Therefore, alternative diagnostic tools and subsequent adjustments in the treatment guidelines are urgently needed. Herein, we summarize the current evidence on recent diagnostic developments to improve risk stratification in bicuspid aortic valve aortopathy, including circulating microRNAs as biomarkers to predict the progression of aortic disease.

U2 - 10.1177/0218492320927233

DO - 10.1177/0218492320927233

M3 - SCORING: Review article

C2 - 32498553

VL - 30

SP - 947

EP - 953

JO - ASIAN CARD THORAC AN

JF - ASIAN CARD THORAC AN

SN - 0218-4923

IS - 8

ER -